🔎 Trials Near Me

Home › Cancer (all types) › Texas › San Antonio

Cancer (all types) clinical trials in San Antonio, TX

41 studies for Cancer (all types) are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559

A Study of PHN-012 in Patients With Advanced Solid Tumors

RecruitingPhase 1
  • PHN-012-001 Site, San Antonio
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07127874

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics (START), San Antonio
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06884618

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07612176

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

RecruitingPhase 2
  • Mays Cancer Center ( Site 0039), San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06979596

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

RecruitingPhase 1
  • GSK Investigational Site, San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07438782

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

RecruitingPhase 1
  • NEXT Oncology ( Site 0151), San Antonio
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07600749

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

RecruitingPhase 3
  • START San Antonio ( Site 0104), San Antonio
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology San Antonio, San Antonio
  • START Texas, San Antonio
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

RecruitingPhase 2/3
  • Sam Clinical Research Center, San Antonio
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

RecruitingPhase 1/2
  • The Cancer Therapy and Research Center at UTHSCSA, San Antonio
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07098806

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RecruitingPhase 3
  • Texas Oncology-San Antonio Cancer Care, San Antonio
  • Texas Oncology - San Antonio Northeast, San Antonio
  • Texas Oncology - San Antonio Stone Oak, San Antonio
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612

Prostate Active Surveillance Study

RecruitingObservational study
  • University of Texas Health Science Center, San Antonio, San Antonio
Ages 21 and older · Men · Updated Sep 2, 2026 · NCT00756665

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Children's Hospital of San Antonio, San Antonio
  • Methodist Children's Hospital of South Texas, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Site 01, San Antonio
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07276373

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

RecruitingPhase 1
  • NEXT Oncology San Antonio, San Antonio
  • START- San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06759649

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • UT Health Mays Cancer Center, San Antonio
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT06067841

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

RecruitingPhase 1
  • START San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06880549

IDOV-Immune for Advanced Solid Tumors

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, San Antonio
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06910657

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

RecruitingPhase 3
  • Texas Oncology San Antonio Medical Center, San Antonio
Ages 18 and older · Women · Updated Jul 28, 2026 · NCT07022483

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • START San Antonio, LLC., San Antonio
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06997029

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

RecruitingPhase 1
  • USA Clinical Trials, San Antonio
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT07103018

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • START San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • START, San Antonio
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RecruitingPhase 1
  • Context Investigational Site, San Antonio
  • Context Investigational Site, San Antonio
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RecruitingPhase 1
  • Research Site #2, San Antonio
  • Research Site, San Antonio
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06835569

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

RecruitingPhase 1
  • GSK Investigational Site, San Antonio
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT06551142

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

RecruitingPhase 1/2
  • NEXT Oncology, San Antonio
Ages 18 to 75 · All sexes · Updated Apr 24, 2026 · NCT06385925

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • NEXT San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT06959706

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • NEXT Oncology San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT07424547

An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

RecruitingPhase 1
  • UT Health, San Antonio
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT04443088

A Study of YL242 in Subjects With Advanced Solid Tumors

RecruitingPhase 1/2
  • US-207, San Antonio
Ages 18 and older · All sexes · Updated Dec 24, 2025 · NCT07197827

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 to 99 · All sexes · Updated Dec 3, 2025 · NCT07021898

Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Ages 18 and older · All sexes · Updated Nov 13, 2025 · NCT05661461

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

RecruitingPhase 1/2
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Jan 7, 2025 · NCT06090266

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
  • University of Texas Health Science Center at San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.